Efficacy and safety of combinational therapy using topical minoxidil and microneedling for the treatment of androgenetic alopecia: a systematic review and meta-analysis

被引:0
作者
Parsa Abdi
Christian Awad
Michelle R. Anthony
Christopher Farkouh
Bret Kenny
Howard I. Maibach
Boluwaji Ogunyemi
机构
[1] Memorial University of Newfoundland Faculty of Medicine,College of Medicine
[2] University of Arizona,Department of Dermatology and Skin Science
[3] Rush Medical College,Division of Dermatology
[4] University of British Columbia Faculty of Medicine,Division of Dermatology
[5] School of Medicine,undefined
[6] University of California,undefined
[7] San Francisco,undefined
[8] Memorial University of Newfoundland Faculty of Medicine,undefined
来源
Archives of Dermatological Research | 2023年 / 315卷
关键词
Androgenetic alopecia; Topical minoxidil; Rogaine; Microneedling; Dermarolling; Hair loss;
D O I
暂无
中图分类号
学科分类号
摘要
Androgenetic alopecia is a widespread condition that is the most common type of hair loss affecting approximately 58% and 40% of men and women by the age of 50, respectively. Patients have been known to experience severe distress due to androgenetic alopecia, including anxiety, low self-esteem, and depression. The objective of this study was to conduct a systematic review and meta-analysis to determine the efficacy of combination therapy using topical minoxidil and microneedling compared to topical minoxidil alone. This systematic review of randomized controlled trials was carried out using the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist. The literature search was performed using Scopus, Cochrane, Embase, and the National Institutes of Health’s United States National Library of Medicine from inception through January 20, 2023. Randomized controlled trials examining the efficacy of combinational therapy and monotherapy using microneedling and minoxidil on patients with clinically diagnosed androgenetic alopecia were included after screening titles, abstracts, and full texts. Two independent reviewers selected studies, extracted data, and appraised the risk of bias using the Cochrane risk of bias assessment tool. Ten randomized controlled trials, including 466 patients, were selected for this review and eight studies were ultimately included in the meta-analysis. All eight studies displayed a statistically significant increase in total hair count [standard mean difference (SMD) 1.76; 95% CI 1.26–2.26; P < 0.00001]; however, the evidence did not support a statistically significant increase in hair diameter (SMD 0.82; 95% CI − 0.01 to 1.65; P = 0.05). No scarring nor serious adverse events were reported in any of the studies. The findings of this meta-analysis strongly support the utilization of a multimodal therapeutic approach of minoxidil and microneedling for hair growth in patients with androgenetic alopecia. However, variations in factors such as rating scale measurements, microneedling methods, and areas of treatment may have resulted in confounding. Further randomized controlled, large-sample trials employing rigorous methodologies are needed to gain a more comprehensive understanding regarding treatment efficacy, namely the impact of combinational therapy on hair diameter.
引用
收藏
页码:2775 / 2785
页数:10
相关论文
共 107 条
[1]  
Ustuner ET(2013)Cause of androgenic alopecia: crux of the matter Plast Reconstr Surg Glob Open 1 e64-1215
[2]  
Imperato-McGinley J(1974)Steroid 5α-reductase deficiency in man: an inherited form of male pseudohermaphroditism Science 186 1213-133
[3]  
Guerrero L(2009)Male androgenetic alopecia: population-based study in 1,005 subjects Int J Trichol 1 131-706
[4]  
Gautier T(2015)Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy J Am Acad Dermatol 73 705-377
[5]  
Peterson RE(2002)Hair pain (trichodynia): frequency and relationship to hair loss and patient gender Dermatol Basel Switz 205 374-2786
[6]  
Krupa Shankar D(2019)Minoxidil and its use in hair disorders: a review Drug Des Dev Ther 13 2777-125
[7]  
Chakravarthi M(2004)An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia Dermatology 209 117-143
[8]  
Shilpakar R(2019)Evaluation of long-term efficacy of finasteride in Korean men with androgenetic alopecia using the basic and specific classification system J Dermatol 46 139-263
[9]  
Shannon F(2015)Response to microneedling treatment in men with androgenetic alopecia who failed to respond to conventional therapy Indian J Dermatol 60 260-298
[10]  
Christa S(2017)Review of applications of microneedling in dermatology Clin Cosmet Investig Dermatol 10 289-6991